MBIO vs FBIO โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
FBIO Captures Institutional Edge (3โ1 Pillars ยท 8โ2 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Fortress Biotech, Inc. (FBIO) driven by superior Valuation, Growth & Margin, Options & Structure while MBIO counters with relative strength in Momentum & Technical. Fundamentally, MBIO trades at N/M Forward P/E with 0.0% operating margin (+0.0% YoY revenue) versus FBIO at 1.2x Forward P/E and -42.8% operating margin (+8.7% YoY). In options structure, MBIO sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against FBIO sits in BREAKDOWN (41st %ile IV; Dealer Gamma Walls on Pro).
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | MBIO | FBIO | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $3.2M | $62.7M | Larger Scale | FBIO |
| Trailing P/E Ratio Valuation | N/M | 0.7x | Lower Multiple | FBIO |
| Forward P/E Ratio Valuation | N/M | 1.2x | Lower Multiple | FBIO |
| Revenue Growth (YoY) Growth | +0.0% | +8.7% | Higher Growth | FBIO |
| Operating Margin (TTM) Profitability | 0.0% | -42.8% | Higher Margin | MBIO |
| Net Profit Margin Profitability | 0.0% | 143.1% | Higher Margin | FBIO |
| Return on Equity (ROE) Capital Efficiency | -43.1% | 102.5% | Higher ROE | FBIO |
| 52-Week Range Position Momentum | 4% ($0โ$1) | 0% ($2โ$5) | Stronger Trend | MBIO |
| Beta / 30D Volatility Risk Regime | 0.66ฮฒ ยท 86% Vol | 1.24ฮฒ ยท 64% Vol | Lower Realized Risk | FBIO |
| Unified Institutional Score Composite Signal | 42.9 / 100 (HOLD) | 50.4 / 100 (HOLD) | Higher Composite | FBIO |